4/A

PRIMARY DOCUMENT

Company: Sarepta Therapeutics, Inc.
Filed: April 22, 2015
Period of Report: February 27, 2015
Accession Number: 0001325812-15-000026

View Document ↗ View on SEC.gov ↗